• 11 - First-line BMT for Severe Aplastic Anemia, Pt. 1: Outcomes and Equity

  • Jun 11 2024
  • Length: 26 mins
  • Podcast

11 - First-line BMT for Severe Aplastic Anemia, Pt. 1: Outcomes and Equity

Listen for free

View show details

  • Summary

  • In this two-part episode, Amy DeZern, MD, MHS, with Johns Hopkins and Christin DeStefano, MD, with Uniformed Services University discuss bone marrow transplant as a first-line treatment for severe aplastic anemia, moving beyond the limitations of traditional immunosuppressive therapies for a curative treatment option.

    In Part I: Outcomes and Equity, guests explore the benefits of haploidentical transplant, noting quicker recovery times and reduced complications compared to past methods. These advancements are particularly impactful for diverse populations, including military personnel.

    To read bios on the panelists and to access additional resources related to this episode, visit Our Site.

    Show more Show less
Show more Show less
activate_Holiday_promo_in_buybox_DT_T2

What listeners say about 11 - First-line BMT for Severe Aplastic Anemia, Pt. 1: Outcomes and Equity

Average customer ratings

Reviews - Please select the tabs below to change the source of reviews.

Audible.com reviews

Amazon reviews
No Reviews are Available